Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
![](https://solvecfs.org/wp-content/uploads/2022/10/cdc-XLhDvfz0sUM-unsplash-1024x683.jpg)
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]